⌘K

Login Start Free

Home/Filings/4/0001346302-21-000060

4//SEC Filing

HALKUFF DAWN 4

Accession 0001346302-21-000060

CIK 0001346302other

View on SEC.gov Company Profile

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 7:09 PM ET

Size

5.3 KB

Accession

0001346302-21-000060

Insider Transaction Report

Form 4

Period: 2021-06-08

XERIS PHARMACEUTICALS INCXERS

Director

Transactions

Award
Stock Option (Right to Buy)
2021-06-08+11,228→ 11,228 total
Exercise: $3.90Exp: 2031-06-08→ Common Stock (11,228 underlying)

Footnotes (1)

[F1]Such options will vest in full upon the earlier to occur of June 8, 2022 or the date of the Company's next annual meeting of stockholders.

Documents

1 file

4
wf-form4_162319374400964.xmlPrimary
FORM 4

Issuer

XERIS PHARMACEUTICALS INC

CIK 0001346302

Entity typeother

Related Parties

1

filerCIK 0001743658

Filing Metadata

Form type: 4
Filed: Jun 7, 8:00 PM ET
Accepted: Jun 8, 7:09 PM ET
Size: 5.3 KB

View on SEC.gov